Ian is a partner based in London with Norton Rose Fulbright. He focuses in advising on all aspects of competition law with a particular focus on competition and cartel investigations and merger control. Ian has been involved in numerous significant cases in recent years, including acting for Asda in the UK Tobacco investigation and successful appeal ; acting for PwC in the UK Audit market investigation ; securing EU and other global merger control clearances in Delta/Virgin Atlantic and the $13.6 billion Thermo Fisher/Life Technologies transaction ; and representing Stena in securing unconditional clearance before the Competition Commission in Stena/DFDS. Ian has also acted for parties in cartel investigations in the air passenger, air freight ; groceries and freight forwarding sectors before UK, EU and other global regulators. Ian was Assistant Director of Competition Policy at the UK Office of Fair Trading (OFT) in 2008-9, which gives him particular insights as to the regulatory approach and perspective. Ian is a frequent speaker and author on competition issues, has been an Editor of Butterworth’s Competition Law and is an active member of the UK International Chamber of Commerce Competition Group. Ian is also a regular media commentator, including with the BBC, CNBC, the Wall Street Journal, the Financial Times, and the Guardian.
Nominee, 2022 Antitrust Writing Awards : Business, Mergers
Nominee, 2022 Antitrust Writing Awards : Business, Cross-Border Issues
Nominee, 2021 Antitrust Writing Awards : Business, Procedure
Nominee, 2021 Antitrust Writing Awards : Business, Cross-border issues
Nominee, 2020 Antitrust Writing Awards : Business, Cross-Border Issues
Nominee, 2020 Antitrust Writing Awards : Business, Concerted Practices
Nominee, 2019 Antitrust Writing Awards : Business, Unilateral Conduct
Nominee, 2019 Antitrust Writing Awards : Business, Concerted Practices
Nominee, 2018 Antitrust Writing Awards : Business, Cross-Border Issues
103
This article has been nominated for the 2022 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. On March 16, the US Federal Trade Commission, US Department of Justice, offices of US state Attorneys General, the Canadian Competition Bureau, the European (...)
48
This article has been nominated for the 2022 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. Introduction The National Security and Investment Bill (the Bill) is currently making its way through the legislative process in the House of Lords. It is (...)
90
This article has been nominated for the 2020 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. Syndicated lending is a well-established and critical way of banks sharing risk in financing larger or riskier projects which a single lender is unable or (...)
55
This article has been nominated for the 2020 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. One of the most significant challenges facing companies dealing with the proliferation of global competition regimes is inconsistencies in approach, timelines, (...)
274
This article has been nominated for the 2019 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. On 7 June 2018, the Competition Appeal Tribunal (CAT) set aside in part the 2016 decision of the Competition and Markets Authority (CMA) that Pfizer and Flynn (...)
687
Major victory for Intel as CJEU sends case back to General Court for re-examination* On 6 September, the EU’s highest court, the Court of Justice (CJEU), released its long-awaited decision in the Intel case, in which the Commission imposed a fine of €1.06 billion – at the time, the largest (...)
Prix
200,00 €
Perspectives on Antitrust Compliance
